Adam M. Sonabend

Northwestern University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.1kcitations21works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(14), RNA Interference and Gene Delivery(13), CAR-T cell therapy research(7), Glioma Diagnosis and Treatment(3), CRISPR and Genetic Engineering(2)

Publications20 total

IMMU-24. CHEK2 haploinsufficiency drives immune responsiveness in aggressive meningiomas
Neuro-Oncology·2025Open Access
Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors
Oncotarget·2025· 3 citedOpen Access
EXTH-11. PEDIATRIC GLIOMA IMMUNE PROFILING IDENTIFIES TIM3 AS A THERAPEUTIC TARGET IN BRAF-FUSION PILOCYTIC ASTROCYTOMA
Neuro-Oncology·2024Open Access
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma
Journal of Clinical Investigation·2024· 13 citedOpen Access
A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery
Journal of Clinical Neuroscience·2012· 34 citedOpen Access
Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy
Molecular Medicine·2010· 198 citedOpen Access
Cancer Stem Cells: The Final Frontier for Glioma Virotherapy
Stem Cell Reviews and Reports·2010· 43 cited
Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy
Current Gene Therapy·2009· 17 citedOpen Access
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
British Journal of Cancer·2009· 70 citedOpen Access
Gene Therapy for Malignant Glioma
2009· 2 cited
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
Gene Therapy·2008· 131 citedOpen Access
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
Cancer Gene Therapy·2008· 36 citedOpen Access
Vector therapies for malignant glioma: shifting the clinical paradigm
Expert Opinion on Drug Delivery·2008· 9 cited
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Stem Cells·2008· 254 cited
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy
International Journal of Oncology·2007· 20 citedOpen Access
Comparative evaluation of survivin, midkine, and CXCR4 promoters for transcriptional targeting of glioma gene therapy
Cancer Biology & Therapy·2007· 52 citedOpen Access
Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus
Molecular Cancer Therapeutics·2006· 38 cited
Oncogenesis and mutagenesis of pituitary tumors
Expert Review of Anticancer Therapy·2006· 9 cited
Oncolytic adenoviral therapy for glioblastoma multiforme
Neurosurgical FOCUS·2006· 56 citedOpen Access
Conditionally replicative adenoviral vectors for malignant glioma
Reviews in Medical Virology·2006· 21 cited

Frequent Co-authors

Ilya V. Ulasov(15), Maciej S. Lesniak(15), Matthew A. Tyler(7), Amy B. Heimberger(4), Sumon Nandi(3), Yu Han(3), Craig Horbinski(3), Ángel A. Rivera(2), J. Michael Mathis(2), Mahua Dey(2), Andrey Khramtsov(2), Yu Han(2), Lisa B. Rivera(2), Shashwat Tripathi(2), Hinda Najem(2), Corey Dussold(2), Sebastián Pacheco(2), Ruochen Du(2), Moloud Sooreshjani(2), Roger Stupp(2)